How Symptoms Can Help Guide Antidepressant Selection

People with the same diagnosis of depression can experience very different symptoms.

One person may feel deeply sad and anxious. Another may feel emotionally flat and unable to enjoy anything. Someone else may mainly struggle with fatigue, poor concentration and difficulty getting started.

These differences matter because serotonin, dopamine and norepinephrine play different—but overlapping—roles in mood, motivation, attention, reward and stress. Research has long suggested that different symptom patterns may be associated with different neurotransmitter systems, although no symptom can tell us the exact amount of a neurotransmitter in a person’s brain.

For this reason, it is better to say that symptoms provide clues about how certain brain systems may be functioning, rather than saying that symptoms directly measure “serotonin levels” or “dopamine levels.”

A simple way to think about it is:

1. Symptoms
2. Provide clues about which brain systems may be under- or overactive
3. Help identify which medication mechanisms may be worth considering
4. Support more personalized medication selection

Can Symptoms Tell Us Which Neurotransmitter Is Low?

Not with certainty.

There is currently no routine clinical test that can look at a person’s symptoms and say:

“Your serotonin is 30% low”

or:

“Your dopamine is too low.”

The brain is much more complicated than that.

Serotonin, dopamine and norepinephrine interact with one another, and the effect of a neurotransmitter depends on where in the brain it is acting.

For example, norepinephrine may be too low in brain areas responsible for attention and mental energy while being overly active in areas involved in stress and anxiety.

So the more useful question is not:

“Which chemical is low?”

but:

“Which pattern of symptoms suggests that a particular brain system may need greater attention?”

What Symptoms May Suggest a Serotonin-Related Pattern?

Serotonin is involved in:

• Mood

• Anxiety

• Emotional regulation

• Repetitive thinking

• Irritability

• Stress responses

• Sleep A person whose depression includes a strong pattern of:

• Low mood

• Persistent worry

• Anxiety

• Irritability

• Repetitive negative thinking

• Emotional sensitivity may have symptoms in which serotonergic regulation is particularly relevant.

This does not mean the person simply has: “Low serotonin.”

It means that serotonin-related pathways may be among the systems involved in their symptoms.

Which Medications Mainly Target Serotonin?

When serotonin-related symptoms are prominent, a physician may consider medications whose main effect is on the serotonin system.

These can include: SSRIs such as:

• Sertraline
• Escitalopram
• Citalopram
• Fluoxetine
• Paroxetine These medications primarily increase serotonin signaling by blocking the serotonin transporter.

Other medications modify serotonin in somewhat different ways, such as:

Vilazodone- which combines serotonin reuptake inhibition with 5-HT1A receptor activity,

Vortioxetine- which affects the serotonin transporter as well as several different serotonin receptors.

The medication chosen still depends on the patient’s complete clinical picture, not serotonin-related symptoms alone.

What Symptoms May Suggest a Dopamine-Related Pattern?

Dopamine is strongly involved in:

• Motivation

• Reward

• Pleasure

• Interest

• Getting started

• Attention

• Goal-directed behaviour A person whose depression is dominated by:

• Loss of pleasure

• Lack of interest

• Low motivation

• Difficulty starting tasks

• Feeling emotionally flat

• Reduced reward from normally enjoyable activities

• Mental sluggishness

• Poor concentration may have a symptom pattern in which dopamine-related pathways are particularly relevant.

One of the clearest examples is:

Anhedonia

Anhedonia means:

Difficulty experiencing pleasure or reward.

This is one of the core symptoms of depression and is closely connected with reward circuits involving dopamine, although several other neurotransmitters also contribute.

Which Medications May Be Considered When Motivation and Reward Symptoms Are Prominent?

A physician may consider whether a medication with greater involvement of:

Dopamine and: Norepinephrine could be useful.

One example is:

Bupropion

which increases dopamine and norepinephrine signaling rather than primarily increasing serotonin.

This does not mean:

“Low motivation means prescribe bupropion.”

Instead, symptoms such as severe anhedonia, low drive or persistent fatigue may be one part of the reasoning when a physician is deciding among several appropriate antidepressants.

This can become particularly relevant when a patient has improved on an SSRI in terms of sadness or anxiety but continues to experience:

Low motivation, lack of pleasure or emotional flatness.

What Symptoms May Suggest a Norepinephrine-Related Pattern?

Norepinephrine helps regulate:

• Energy

• Alertness

• Attention

• Mental effort

• Wakefulness

• The response to stress. Low or inefficient norepinephrine signaling in attention-related brain systems may be associated with symptoms such as:

• Fatigue

• Low mental energy

• Difficulty concentrating

• Difficulty staying alert

• Slowed thinking

• Difficulty sustaining attention Research has particularly linked energy, vigilance and arousal with norepinephrine-related systems, although there is substantial overlap with dopamine and serotonin.

Which Medications Affect Both Serotonin and Norepinephrine?

If a patient has depression accompanied by symptoms such as:

Low mood + fatigue + poor concentration + low mental energy

a physician may consider a medication affecting both serotonin and norepinephrine.

These include:

SNRIs — Serotonin-Norepinephrine Reuptake Inhibitors

such as:

• Venlafaxine
• Desvenlafaxine
• Duloxetine
• Levomilnacipran These medications increase signaling through both systems.

For some patients, this broader mechanism may be useful when a purely serotonergic treatment has improved mood or anxiety but has not sufficiently improved:

Energy, alertness or concentration.

Norepinephrine Is More Complicated Than Simply “Low” or “High”

This is especially important.

A person can appear to have:

Too little norepinephrine activity in one brain region

and:

Too much norepinephrine activity in another.

For example:

Prefrontal Cortex

Appropriate norepinephrine activity helps support:

• Attention
• Working memory
• Concentration
• Mental energy
• Executive function Too little activity may contribute to:

Fatigue and poor concentration.

Amygdala and Stress Circuits

Norepinephrine also activates systems involved in:

• Threat detection

• Vigilance

• Stress

• Fight-or-flight responses Too much activity in these systems may contribute to:

• Anxiety

• Hypervigilance

• Feeling constantly “on edge”

• Difficulty relaxing

• Physical arousal This illustrates why:

The same neurotransmitter can be helpful in one part of the brain and excessive in another.

What About a Patient Who Is Both Tired and Anxious?

This is common.

A patient may report:

Low energy and poor concentration

suggesting insufficient activation in attention-related systems,

while simultaneously experiencing:

Anxiety, hypervigilance and excessive stress responses.

That does not necessarily mean the symptoms contradict one another.

Different brain circuits may be functioning differently.

This is why a physician cannot simply say:

“The patient needs more norepinephrine.”

The goal is to choose a medication whose overall mechanism is appropriate for the whole symptom pattern.

A Simple Way to Look at Symptom Patterns

Prominent symptoms	Brain system that may be particularly relevant	Medication mechanisms a physician may consider
Sadness, worry, anxiety, repetitive negative thinking, emotional reactivity	Serotonin-related regulation	SSRIs or other serotonergic antidepressants
Low mood + fatigue + poor concentration + low mental energy	Serotonin + norepinephrine pathways	SNRIs
Loss of pleasure, low motivation, low drive, difficulty getting started	Dopamine/reward pathways, often with norepinephrine	Bupropion or other appropriate strategies affecting DA/NE
Anxiety + low mood + low energy	Mixed serotonin, norepinephrine and stress pathways	SSRI or SNRI depending on overall profile
Prominent insomnia, poor appetite and anxiety	Multiple systems including serotonin, histamine and norepinephrine	A medication such as mirtazapine may sometimes be considered
Partial response to an SSRI but persistent anhedonia/fatigue	Residual dopamine/norepinephrine-related symptoms may be relevant	Switching or augmentation may be considered

This table is a clinical framework, not a diagnostic test.

Why Symptoms Should Not Be Treated as a Chemical Test

It would be tempting to say:

Sadness = low serotonin

Low motivation = low dopamine

Fatigue = low norepinephrine

But that would be too simplistic.

All three neurotransmitters interact.

For example:

Poor concentration

can involve dopamine, norepinephrine, serotonin, sleep, anxiety or several systems at once.

Low motivation

can arise from dopamine-related reward dysfunction, but can also result from severe anxiety, exhaustion or sleep disturbance.

Anxiety

can involve serotonin, norepinephrine, GABA, glutamate and stress-hormone systems.

Research supports associations between certain symptom clusters and neurotransmitter systems, but there is considerable overlap between them.

That is why the safest and most useful term is:

Neurotransmitter pattern

rather than:

Neurotransmitter level

How Can Symptoms Help a Physician Choose an Antidepressant?

Instead of treating every patient with depression as biologically identical, the physician can look at:

Which symptoms are most prominent?

For example:

Is the patient mainly struggling with:

Anxiety and repetitive negative thinking?

or:

Low motivation and loss of pleasure?

or:

Fatigue and poor concentration?

or:

Hyperarousal and insomnia?

or:

A combination of these?

This can help identify which medication mechanisms may be worth considering first.

Example 1: Depression Dominated by Anxiety and Repetitive Thinking

A patient reports:

• Persistent sadness
• Excessive worry
• Repetitive negative thoughts
• Emotional reactivity
• Irritability The clinician may consider that:

Serotonin-related regulation appears particularly relevant.

A serotonergic medication such as an:

SSRI

may therefore be a reasonable option.

Example 2: Depression Dominated by Fatigue and Poor Concentration

Another patient reports:

• Low mood
• Severe fatigue
• Low mental energy
• Difficulty concentrating
• Difficulty staying alert The physician may consider whether a medication affecting:

Serotonin + norepinephrine

could better address the overall symptom profile.

An:

SNRI

may therefore be considered.

Example 3: Depression Dominated by Anhedonia and Low Motivation

Another patient says:

“I am not particularly anxious anymore. I just don’t enjoy anything, I have no motivation and I can’t get myself started.”

That symptom pattern may draw attention to:

Dopamine-related reward and motivation systems.

A physician may therefore consider whether a medication with stronger:

Dopamine and norepinephrine activity

such as bupropion, might be worth considering.

Example 4: An SSRI Helped Anxiety but Motivation Became Worse

A patient may say:

“I worry less and I don’t feel as sad, but I feel flat. I have no motivation and nothing feels rewarding.”

This is important information.

The SSRI may have successfully helped one part of the illness:

Serotonin-related anxiety or mood symptoms

while:

Reward, motivation or energy symptoms remain.

At this point, the physician may consider:

• Switching medication
• Adding another antidepressant
• Using an antidepressant with a broader mechanism
• Considering an adjunctive treatment This is one reason treatment should evaluate individual symptoms, not simply whether the patient is “better” or “not better.”

Symptoms Can Also Help Identify What a Medication Should Avoid

Symptoms do not only indicate what a patient may need more of.

They can also identify pathways that should be approached carefully.

For example, a patient with:

• Severe anxiety
• Panic
• Hypervigilance
• Insomnia
• Feeling constantly on edge may be particularly sensitive to a strongly activating medication.

Likewise, a patient already experiencing:

Severe fatigue

may not tolerate a medication that causes substantial sedation.

Medication selection therefore involves balancing:

What symptoms need improvement

against:

What symptoms the medication might worsen.

How Does This Fit with Current Antidepressant Guidelines?

Current depression guidelines already encourage individualized antidepressant selection rather than treating every antidepressant as interchangeable.

Factors considered include:

• The patient’s symptom profile
• Previous medication response
• Previous side effects
• Other medical conditions
• Other medications
• Safety
• Patient preference CANMAT notes that many clinical and medication factors influence antidepressant choice and that there are few absolute rules linking a particular clinical feature to one specific antidepressant.

This is important.

The goal is not to create a rule such as: “Fatigue means SNRI.”

Instead, symptoms provide another source of information that can help physicians decide among several reasonable treatment choices.

Adding Genetics Can Provide Another Layer of Information

Symptoms tell us: What the patient is experiencing.

Pharmacogenomics can provide information about:

How that patient may process or respond to certain medications.

These two types of information can complement each other.

For example:

1. Symptoms
2. Suggest which medication mechanism may be useful

then:

1. Genetics
2. Helps assess whether particular medications within that class may be more or less suitable

For example, a symptom profile may suggest considering an SSRI.

PGx information may then help determine whether:

• One SSRI is metabolized normally
• Another may reach unusually high levels
• Another may be cleared too rapidly
• Certain biological pathways appear more or less favourable

Symptoms + Genetics + Clinical History

A more personalized approach can therefore combine three forms of information:

Symptoms

1. What does this patient need the medication to improve?
2. 2. Genetics
3. How is this patient likely to handle and respond to different medications?
4. 3. Clinical history
5. What has already worked, failed or caused side effects?
6. More informed medication selection

This may be more useful than asking only:

“What is the standard medication for depression?”

From Diagnosis-Based Prescribing to Symptom-Based Prescribing

Two patients may both have:

Major Depressive Disorder

but their symptoms can look completely different.

Patient A

SadnessAnxiety

Worry

Repetitive thinking

Emotional sensitivity

Patient B

Loss of pleasureLow motivation

Low energy

Poor concentration

Mental slowing

The diagnosis may be the same.

But the underlying symptom pattern is different.

This raises a useful clinical question:

Should both patients automatically receive a medication with exactly the same mechanism?

Sometimes the answer will still be yes.

But looking carefully at symptoms provides an opportunity to make the choice more individualized.

The Goal Is Not to Measure Neurotransmitters from Symptoms

Symptoms should not be presented as a laboratory measurement of brain chemistry.

A physician cannot accurately determine a patient’s exact serotonin, dopamine or norepinephrine concentration from a questionnaire.

Instead, symptoms can be used to identify:

Patterns of brain function

that may be consistent with greater involvement of certain neurotransmitter systems.

A scientifically responsible way to describe this is:

A patient’s symptoms may provide clues about which neurotransmitter systems and brain networks are most involved in their illness. These clues can help clinicians consider medication classes that act on those systems, while also taking into account diagnosis, medical history, previous treatment, side effects, genetics and patient preference.